Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Senti Biosciences (SNTI) Institutional Ownership

Senti Biosciences logo
$0.88 -0.06 (-6.35%)
Closing price 04:00 PM Eastern
Extended Trading
$0.89 +0.01 (+0.98%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Senti Biosciences (NASDAQ:SNTI)

Current
Institutional Ownership
Percentage
25.70%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$2.33M
Number of
Institutional Sellers
(last 12 months)
0
Get SNTI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Senti Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SNTI Institutional Buying and Selling by Quarter

Senti Biosciences Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2026 Virtu Financial LLC44,409$46K0.0%N/A0.169%
2/12/2026 Jane Street Group LLC38,427$40K0.0%N/A0.146%
11/17/2025 Citadel Advisors LLC82,753$117K0.0%N/A0.316%
8/14/2025 Armistice Capital LLC892,207$1.88M0.0%N/A3.411%
8/8/2025 Geode Capital Management LLC147,314$311K0.0%+395.6%0.565%
5/15/2025Nantahala Capital Management LLC888,000$2.98M0.1%N/A3.405%
5/15/2025Heights Capital Management Inc.750,000$2.52M1.3%N/A2.876%
2/13/2025Renaissance Technologies LLC51,600$181K0.0%N/A1.071%
2/11/2025Virtu Financial LLC13,356$47K0.0%N/A0.277%
11/14/2024NEA Management Company LLC442,615$1M0.1%-90.0%9.664%
11/7/20248VC GP I LLC253,755$573K0.8%-90.0%5.541%
10/31/2024ARK Investment Management LLC176,666$399K0.0%-88.9%3.858%
7/26/2024ARK Investment Management LLC1,585,772$438K0.0%-2.8%34.624%
2/12/20248VC GP I LLC2,537,558$1.68M1.7%N/A5.697%
1/17/2024ARK Investment Management LLC1,969,860$1.30M0.0%+7.9%4.423%
10/27/2023TD Asset Management Inc241,208$102K0.0%+88.4%0.542%
9/7/2023Triatomic Management LP300,533$188K0.2%+42.5%0.675%
7/10/2023ARK Investment Management LLC1,829,815$1.15M0.0%-3.8%4.143%
5/3/2023Triatomic Management LP210,883$249K0.2%+39.0%0.477%
4/17/2023ARK Investment Management LLC1,901,467$2.24M0.0%-1.3%4.305%
2/14/2023Triatomic Management LP151,675$214K0.2%+168.7%0.346%
2/13/2023Artal Group S.A.55,555$78K0.0%-94.7%0.127%
2/7/2023TD Asset Management Inc118,292$167K0.0%-12.3%0.270%
1/24/2023ARK Investment Management LLC1,925,827$2.72M0.0%-7.8%4.391%
11/15/2022Triatomic Management LP56,454$123K0.1%N/A0.129%
11/7/2022TD Asset Management Inc.134,892$285K0.0%+53.8%0.308%
11/3/2022The Manufacturers Life Insurance Company117,707$248K0.0%N/A0.269%
10/17/2022ARK Investment Management LLC2,087,696$4.53M0.0%N/A4.771%
8/11/2022Artal Group S.A.1,055,555$2.07M0.1%N/A4.450%
8/8/2022Allen Operations LLC21,443$42K0.0%N/A0.090%
8/4/2022TD Asset Management Inc.87,696$172K0.0%N/A0.370%
7/29/2022Kingfisher Capital LLC113,163$222K0.1%N/A0.477%


SNTI Institutional Ownership - Frequently Asked Questions

During the previous two years, 11 institutional investors and hedge funds held shares of Senti Biosciences. The most heavily invested institutionals were Nantahala Capital Management LLC ($2.98M), Heights Capital Management Inc. ($2.52M), Armistice Capital LLC ($1.88M), NEA Management Company LLC ($1M), 8VC GP I LLC ($573K), ARK Investment Management LLC ($399K), and Geode Capital Management LLC ($311K).Learn more on Senti Biosciences' institutional investors.

25.70% of Senti Biosciences' stock is owned by institutional investors. Learn more on SNTI's institutional investor holdings.

The following institutional investors have purchased Senti Biosciences' stock in the last 24 months: Armistice Capital LLC ($892.21K), Nantahala Capital Management LLC ($888K), Heights Capital Management Inc. ($750K), Geode Capital Management LLC ($117.59K), Citadel Advisors LLC ($82.75K), Virtu Financial LLC ($57.77K), and Renaissance Technologies LLC ($51.60K).

Institutional investors have bought a total of 1,175,384 shares in the last 24 months. This purchase volume represents approximately $2.33M in transactions.


Related Companies

This page (NASDAQ:SNTI) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel